Pharmaceuticals, Biotechnology and Life Sciences
Initiated Phase 3 Trial of SY-1425 in Combination with Azacitidine in RARA-Positive Newly Diagnosed Higher-Risk MDS Patients
On Track to Initiate Two Additional Clinical Trials Across Hematology Franchise in 2H 2021
On Track to Report Additional Dos…
Management to provide corporate update on emerging SARS-CoV-2 variants of concern, (UK, S. African and Brazilian)
VICTORIA, British Columbia–(BUSINESS WIRE)–$IPA #POLYTOPE–IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: …
Major transformation underway as 90% of CROs unify clinical operations
COVID-19 drives advancements in study start-up, collaboration, and execution
BARCELONA, Spain–(BUSINESS WIRE)–Contract research organizations (CROs) are making significant advan…
Major transformation underway as 90% of CROs unify clinical operations
COVID-19 drives advancements in study start-up, collaboration, and execution
PLEASANTON, Calif.–(BUSINESS WIRE)–Contract research organizations (CROs) are making significant adv…
Australian firm takes the lead in genetics and AI-based technology for personalized medical cannabis treatments
IRVINE, Calif.–(BUSINESS WIRE)–#biopharma–GATC Health, an innovative technology company focused on whole genome testing and Predictive M…
BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc., a late- clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune disea…
DUBLIN–(BUSINESS WIRE)–The “Global Cell and Gene Therapy Market: Focus on Product Type, Therapeutic Class, Pipeline, Regional and Country Data (15 Countries) – Analysis and Forecast, 2021-2027” report has been added to ResearchAndMarkets.com’s offeri…
DUBLIN–(BUSINESS WIRE)–The “Tissue Processing Systems Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Product, Volume, and End User and Geography” report has been added to ResearchAndMarkets.com’s offering.
According to this report …
DUBLIN–(BUSINESS WIRE)–The “Europe Organoids Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type; Application; Source” report has been added to ResearchAndMarkets.com’s offering.
Internal Organoids segment is expected to drive th…
Adults with two very rare forms of non-Hodgkin lymphoma will not have access to an innovative systemic treatment following NICE’s decision to not recommend mogamulizumab for routine use in the NHS. Kyowa Kirin is disappointed by this decision but rema…